Bio Protocol (BIO) has been on fire lately, surging more than 80% in just the past week and hitting a six-month high of $0.186. On a monthly basis, the token is up 175%, and since the start of the year, BIO has soared over 340%.
The rally hasn’t come out of nowhere big players are clearly betting on BIO’s future. Data from Nansen shows whale wallets now hold 21.94 million BIO, up from 18.72 million just a week ago and far above the 2 million they held a month back. This steady accumulation by whales often acts as a signal to retail traders, fueling even more demand and upward price pressure.
Public figures have also been jumping in. Their combined holdings skyrocketed from just 3,900 BIO last week to 7.66 million today. Meanwhile, exchange balances have dropped 11.6% since mid-August, a sign that investors are moving tokens into private wallets. When supply on exchanges shrinks, it often reduces selling pressure and can pave the way for further gains.
Adding to the momentum, Bio Protocol just rolled out its first BioAgent, “Aubrai,” on August 21. The launch tied BIO’s utility more directly to biotech applications, boosting investor confidence that the project’s use cases are expanding beyond speculation.
Technical Setup: Golden Cross and Bullish Patterns
From a charting perspective, BIO’s breakout has been just as impressive as the whale activity. After months of trading in the $0.040–$0.100 range, the token broke out in August, confirming a double-bottom pattern a classic sign of a trend reversal.
Now, traders are watching an even more powerful bullish indicator: a golden cross on the daily chart, with the 50-day simple moving average climbing above the 200-day SMA. This formation is often seen as a strong signal that upward momentum could last.
Supporting indicators like the MACD and RSI are also trending higher, further underscoring the strength of the move.
With momentum on its side, the next key target for BIO is the $0.30 psychological level, which lines up with the 1.618 Fibonacci extension. That would mark another 67% jump from current levels.
On the flip side, if bulls lose control, a drop below the $0.10 mark which coincides with the 38.2% Fibonacci retracement could invalidate the bullish setup and open the door to a deeper pullback.
The Bigger Picture
Between whale accumulation, shrinking exchange supply, the golden cross, and the launch of Aubrai, BIO has several tailwinds pointing toward further growth. The token is showing signs of maturity, with fundamentals and technicals both aligning in its favor.
Still, traders should keep in mind that momentum-driven rallies can shift quickly. While $0.30 is within reach, holding above key support levels will be critical in confirming that BIO’s latest run is more than just a short-term spike.
